Atlas Trials

Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients

Clinical trial NCT02473497 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT02473497
Sponsor
Pfizer
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Neoplasm

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.